Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Tom_C
    Member
    • Aug 2012
    • 16

    #1

    New to NGS - Looking for Chip-seq project advice

    My lab is new to NGS, and we are looking to map the regulon of the TyrR transcription factor in our bacterium, E. cloacae. In general, we wish to identify TyrR-DNA interactions in response to the presence or absence of aromatic amino acids, which function as cofactors for TyrR binding. This would give use 12 samples in total, a no AAA control, +TRP, +PHE and +TYR all in triplicate.

    We are thinking on using Illumina sequencing and multiplexing our samples so that they can all be run in a single lane. Is there a good comprehensive resource that details the entire procedure from start to end? I have a good hold on most of the steps involved, but I do not know enough yet to properly decide on how many reads, type of sequencing, etc. Thanks in advance.
  • arolfe
    Member
    • Jul 2011
    • 29

    #2
    I don't know of a comprehensive resource either.

    Question 1: type of sequencing/read length: in general, ChIP-Seq works well with relatively short reads- 35 or 50bp should be fine. You might want longer reads or paired reads if you're interested in binding to repetitive regions that will be hard to tell apart without the extra sequence.

    Question 2: how many reads: This is very hard to answer, as it depends on the number of binding sites, the efficiency of your antibody, and your desired sensitivity (binding isn't binary, so deeper sequencing reveals weaker binding sites).

    We used to do mammalian ChIP-Seq experiments in a GAII lane that would give 5-10m reads. So you could multiplex your 12 samples into a HiSeq lane and get 5m reads per sample, which ought to be plenty unless you're at an extreme of one of the factors I mentioned. It's probably better to overshoot on # of reads for the first try. Then you can sub-sample your data to see how many binding events you lose and use that to calibrate the number of reads for your other two replicates.

    Good luck!

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    41 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...